Plant Cell Expressed Recombinant Human Glucocerebrosidase Extension Trial
NCT00705939
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
45
Enrollment
INDUSTRY
Sponsor class
Conditions
Gaucher Disease
Interventions
DRUG:
Taliglucerase alfa
Sponsor
Pfizer